Scale-ready Cannabinoids PureForm has completed commercial scale-up of CBD and can produce metric ton quantities today, signaling readiness to meet larger supply needs for pharmaceutical and consumer product collaborations.

Sustainable Production The Cyclic Terpene Assembly platform offers a cost-efficient, scalable, and sustainable alternative to plant extraction, enabling reliable long-term supply partnerships with lower risk and improved supply chain economics.

Broad Cannabinoid Library With a catalog of over 100 chirally pure cannabinoids and ongoing development of novel derivatives, there is potential for co-development and licensing opportunities across wellness, nutraceutical, and pharmaceutical segments.

Industry Target Fit Focus on safe, legal, and effective cannabinoid products aligns with consumer and pharma sector demand for compliant ingredients, offering opportunities with contract manufacturers, brand owners, and regulatory-focused distributors.

Lean Collaboration Small team size combined with rapid scaling capability suggests high-value partnerships through white-label or joint development agreements with larger players seeking reliable cannabinoid supply and novel chemistry capabilities.